Moody Lynn & Lieberson LLC boosted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 90.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,296 shares of the company’s stock after purchasing an additional 2,991 shares during the quarter. Moody Lynn & Lieberson LLC’s holdings in Henry Schein were worth $516,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HSIC. YorkBridge Wealth Partners LLC raised its holdings in Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after purchasing an additional 28 shares in the last quarter. Sun Life Financial INC raised its holdings in Henry Schein by 8,185.7% in the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock worth $106,000 after purchasing an additional 573 shares in the last quarter. Trust Co. of Vermont raised its holdings in Henry Schein by 56.7% in the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock worth $140,000 after purchasing an additional 616 shares in the last quarter. Lee Financial Co bought a new position in Henry Schein in the second quarter worth $161,000. Finally, Benjamin F. Edwards & Company Inc. raised its holdings in Henry Schein by 281.8% in the third quarter. Benjamin F. Edwards & Company Inc. now owns 2,100 shares of the company’s stock worth $172,000 after purchasing an additional 1,550 shares in the last quarter. Institutional investors and hedge funds own 53.07% of the company’s stock.

In other news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total transaction of $366,756.26. Following the transaction, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.19% of the stock is owned by insiders.

A number of research firms have issued reports on HSIC. Leerink Swann reiterated a “market perform” rating and issued a $77.00 price objective (down previously from $87.50) on shares of Henry Schein in a report on Tuesday, November 7th. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Stifel Nicolaus decreased their price objective on Henry Schein from $89.00 to $77.00 and set a “hold” rating for the company in a report on Tuesday, November 7th. Royal Bank Of Canada decreased their price objective on Henry Schein from $91.00 to $82.00 and set a “sector perform” rating for the company in a report on Tuesday, November 7th. Finally, TheStreet downgraded Henry Schein from a “b” rating to a “c+” rating in a report on Monday, November 6th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $89.88.

Shares of Henry Schein, Inc. (HSIC) traded down $0.55 during trading hours on Tuesday, reaching $66.50. The company’s stock had a trading volume of 3,873,200 shares, compared to its average volume of 1,118,817. The stock has a market capitalization of $10,523.79, a PE ratio of 18.81, a price-to-earnings-growth ratio of 1.89 and a beta of 1.03. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.86. Henry Schein, Inc. has a fifty-two week low of $65.72 and a fifty-two week high of $93.50.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The company had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.05 billion. During the same period in the previous year, the firm earned $0.84 earnings per share. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. equities analysts forecast that Henry Schein, Inc. will post 3.6 earnings per share for the current year.

Henry Schein announced that its board has initiated a share buyback program on Monday, September 18th that permits the company to repurchase $400.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 6.3% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.dailypolitical.com/2017/11/14/henry-schein-inc-hsic-shares-bought-by-moody-lynn-lieberson-llc.html.

Henry Schein Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.